![](/images/graphics-bg.png)
Administration of Panobinostat Is Associated with Increased IL-17A mRNA in the Intestinal Epithelium of HIV-1 Patients
Joint Authors
Bjerg Christensen, Ane
Dige, Anders
Vad-Nielsen, Johan
Brinkmann, Christel R.
Bendix, Mia
Tolstrup, Martin
Søgaard, Ole S.
Rasmussen, Thomas A.
Randel Nyengaard, Jens
Agnholt, Jørgen
Denton, Paul W.
Østergaard, Lars
Source
Issue
Vol. 2015, Issue 2015 (31 Dec. 2015), pp.1-11, 11 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2015-12-01
Country of Publication
Egypt
No. of Pages
11
Main Subjects
Abstract EN
Intestinal CD4+ T cell depletion is rapid and profound during early HIV-1 infection.
This leads to a compromised mucosal barrier that prompts chronic systemic inflammation.
The preferential loss of intestinal T helper 17 (Th17) cells in HIV-1 disease is a driver of the damage within the mucosal barrier and of disease progression.
Thus, understanding the effects of new therapeutic strategies in the intestines has high priority.
Histone deacetylase (HDAC) inhibitors (e.g., panobinostat) are actively under investigation as potential latency reversing agents in HIV eradication studies.
These drugs have broad effects that go beyond reactivating virus, including modulation of immune pathways.
We examined colonic biopsies from ART suppressed HIV-1 infected individuals (clinicaltrials.gov: NCT01680094) for the effects of panobinostat on intestinal T cell activation and on inflammatory cytokine production.
We compared biopsy samples that were collected before and during oral panobinostat treatment and observed that panobinostat had a clear biological impact in this anatomical compartment.
Specifically, we observed a decrease in CD69+ intestinal lamina propria T cell frequency and increased IL-17A mRNA expression in the intestinal epithelium.
These results suggest that panobinostat therapy may influence the restoration of mucosal barrier function in these patients.
American Psychological Association (APA)
Bjerg Christensen, Ane& Dige, Anders& Vad-Nielsen, Johan& Brinkmann, Christel R.& Bendix, Mia& Østergaard, Lars…[et al.]. 2015. Administration of Panobinostat Is Associated with Increased IL-17A mRNA in the Intestinal Epithelium of HIV-1 Patients. Mediators of Inflammation،Vol. 2015, no. 2015, pp.1-11.
https://search.emarefa.net/detail/BIM-1072118
Modern Language Association (MLA)
Bjerg Christensen, Ane…[et al.]. Administration of Panobinostat Is Associated with Increased IL-17A mRNA in the Intestinal Epithelium of HIV-1 Patients. Mediators of Inflammation No. 2015 (2015), pp.1-11.
https://search.emarefa.net/detail/BIM-1072118
American Medical Association (AMA)
Bjerg Christensen, Ane& Dige, Anders& Vad-Nielsen, Johan& Brinkmann, Christel R.& Bendix, Mia& Østergaard, Lars…[et al.]. Administration of Panobinostat Is Associated with Increased IL-17A mRNA in the Intestinal Epithelium of HIV-1 Patients. Mediators of Inflammation. 2015. Vol. 2015, no. 2015, pp.1-11.
https://search.emarefa.net/detail/BIM-1072118
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1072118